Halofantrine: Uses, Mechanism of Action, Side Effects & Current Status

Halofantrine is an antimalarial medication used to treat acute, uncomplicated malaria caused by Plasmodium falciparum and Plasmodium vivax. As part of the phenanthrene methanol class, it works by interfering with the parasite’s metabolic process, especially disrupting mitochondrial function.

Mechanism of Action

Halofantrine interferes with the malaria parasite’s survival in the human host:

  • Disrupts Mitochondrial Electron Transport
  • Binds to Hematin, preventing the detoxification of heme in the parasite
  • Results in parasite death due to oxidative damage and metabolic collapse

Uses of Halofantrine

Although its clinical use is now limited, Halofantrine once played a crucial role in treating resistant malaria.

1. Treatment of Acute, Uncomplicated Malaria

  • Effective against chloroquine-resistant strains of P. falciparum and P. vivax
  • Used when first-line drugs are ineffective
  • Not suitable for severe malaria (IV treatment like artesunate is preferred)

2. Occasional Use in Travelers

  • Previously used for travelers in high-risk zones with multidrug-resistant malaria
  • Now largely replaced by safer drugs like atovaquone-proguanil and ACTs

3. Historical or Off-Label Use

  • Studied for babesiosis (a tick-borne infection)
  • Not recommended for prophylaxis due to cardiotoxicity

Side Effects & Safety Concerns

Halofantrine’s cardiac risks have significantly reduced its use:

  • QT Prolongation: Can lead to dangerous heart rhythm disturbances such as torsades de pointes
  • Gastrointestinal Issues: Nausea, vomiting, and diarrhea
  • Drug Interactions: Avoid with other QT-prolonging agents (e.g., macrolides, quinidine)
  • Contraindications: Not suitable for individuals with heart disease, electrolyte imbalances, or those on cardiotoxic drugs

Current Status in Global Health

  • Not recommended by WHO due to high cardiac risks
  • Safer alternatives are now preferred:
    • Artemisinin-based Combination Therapies (ACTs)
    • Atovaquone-proguanil (Malarone)
    • Mefloquine or Doxycycline in selected cases

Halofantrine from Amber Lifesciences

As India’s leading pharmaceutical manufacturer, Amber Lifesciences ensures the quality supply of APIs like Halofantrine for research and regulated export purposes.

  • Reliable Exporter India – DGCI and GMP Certified
  • Pharmaceutical Manufacturer for Antimalarial APIs
  • Custom Bulk Supply Options Available

Conclusion

While Halofantrine once offered a solution to drug-resistant malaria, its severe cardiotoxic effects have resulted in limited use today. Amber Lifesciences, as a top pharmaceutical manufacturer and trusted API exporter from India, provides Halofantrine for regulated pharmaceutical needs only, emphasizing safety and compliance.